ZLNA Fundamental Analysis - ZELLUNA ASA

Fundamental Rating

Overall ZLNA gets a fundamental rating of 2 out of 10. We evaluated ZLNA against 73 industry peers in the Biotechnology industry. ZLNA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ZLNA is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

ZLNA had negative earnings in the past year.

ZLNA had a negative operating cash flow in the past year.

In the past 5 years ZLNA always reported negative net income.

ZLNA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -121.94%, ZLNA is not doing good in the industry: 76.71% of the companies in the same industry are doing better.

The Return On Equity of ZLNA (-162.76%) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-121.94%
ROE	-162.76%
ROIC	N/A

ROA(3y)-86.89%

ROA(5y)-61.71%

ROE(3y)-116.09%

ROE(5y)-80.15%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ZLNA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ZLNA has about the same amout of shares outstanding than it did 1 year ago.

ZLNA has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, ZLNA has a worse debt to assets ratio.

2.2 Solvency

ZLNA has an Altman-Z score of 1.43. This is a bad value and indicates that ZLNA is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of ZLNA (1.43) is comparable to the rest of the industry.

There is no outstanding debt for ZLNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	1.43

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 3.55 indicates that ZLNA has no problem at all paying its short term obligations.

With a decent Current ratio value of 3.55, ZLNA is doing good in the industry, outperforming 71.23% of the companies in the same industry.

A Quick Ratio of 3.55 indicates that ZLNA has no problem at all paying its short term obligations.

The Quick ratio of ZLNA (3.55) is better than 71.23% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.55
Quick Ratio	3.55

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ZLNA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.34%.

EPS 1Y (TTM)-7.34%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%44.65%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

ZLNA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.22% yearly.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y87.94%

EPS Next 2Y35.22%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ZLNA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ZLNA. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ZLNA's earnings are expected to grow with 35.22% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y35.22%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ZLNA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ZELLUNA ASA

OSL:ZLNA (6/19/2025, 7:00:00 PM)

13.012

-0.66 (-4.81%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)05-08 2025-05-08

Earnings (Next)08-20 2025-08-20

Inst Owners16.41%

Inst Owner ChangeN/A

Ins Owners1.15%

Ins Owner ChangeN/A

Market Cap263.23M

Analysts42.22

Price Target25.5 (95.97%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-56.52%

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-147.6%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)-100%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	2.07
P/tB	2.29
EV/EBITDA	N/A

EPS(TTM)-55.48

EYN/A

EPS(NY)-7.47

Fwd EYN/A

FCF(TTM)-7.59

FCFYN/A

OCF(TTM)-7.57

OCFYN/A

SpS0

BVpS6.28

TBVpS5.68

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-121.94%
ROE	-162.76%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-86.89%

ROA(5y)-61.71%

ROE(3y)-116.09%

ROE(5y)-80.15%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	12.33%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.55
Quick Ratio	3.55
Altman-Z	1.43

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)2.96%

Cap/Depr(5y)41.24%

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-7.34%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%44.65%

EPS Next Y87.94%

EPS Next 2Y35.22%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y21.53%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year32.28%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y3.58%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y3.73%

OCF growth 3YN/A

OCF growth 5YN/A

ZELLUNA ASA (ZLNA.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens